Pharmacokinetics of Posaconazole in Children With Chronic Granulomatous Disease (CGD)
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find a dose for a twice daily regimen for posaconazole (PSZ)
as prophylactic treatment in children with CGD, based on the PSZ trough level.